×

Celebrating 15 Years of Excellence

Find Out More >
Celebrating 15 Years of Excellence

CFDs and Spread Bets are complex instruments and come with a high risk of losing money rapidly due to leverage. 70.5% of retail investor accounts lose money when trading CFDs and Spread Bets with this provider. You should consider whether you understand how CFDs and Spread Bets work and whether you can afford to take the high risk of losing your money.

Risk Disclosure Notice
  • Vantage 15Vantage 15 Years
  • Institutional

  • LiveREGISTER

  • en
  • Search
View More
SEARCH
  • All
    Trading
    Platforms
    Academy
    Analysis
    Promotions
    About
  • Search
Keywords
Popular Search
  • facebook
  • instagram
  • twitter
  • linkedin
HomeRight Arrow NotificationsRight Arrow Product UpdatesRight Arrow Demerger of the Consumer Healthcare Business from GSK to form Haleon

Back

Product Updates 8 Jul 2022

Demerger of the Consumer Healthcare Business from GSK to form Haleon

NOTIFICATIONS

Please be advised that due to the demerger of the Consumer Healthcare business from GSK to form Haleon, only the closing of current GSK plc (GSK) positions will be made available.

This will take place as per the following schedule:

  • Ex-Date: 11 July 2022

During this corporate action event, no stock dividends will be paid out as Haleon plc is currently not listed. We will notify you if we reopen GSK for trading.

What happened to GSK plc?

On 23 June 2021 at its Investor Update, GSK plc (“GSK” or the “Company”) confirmed its intention to separate its Consumer Healthcare business from the GSK Group to form Haleon plc (“Haleon”), an independent listed company. It is proposed that the separation will be effected by way of a demerger (the “Demerger”) of at least 80% of GSK’s 68% holding in the Consumer Healthcare business to GSK shareholders. 

For the full press release, please refer here.

IN CASE YOU MISSED IT